EXHIBIT 99.1


JOINT FILING AGREEMENT


The undersigned hereby agree that a single Schedule 13G (or any amendment thereto) relating to the common stock of Aardvark Therapeutics, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13G.


Dated:  February 24, 2025


Decheng Capital Global Life Sciences Fund IV, L.P.


By:

Decheng Capital Management IV (Cayman), LLC

Its:

 General Partner


By:

/s/ Xiangmin Cui

Name:  Xiangmin Cui

Title:  Manager



Decheng Capital Management IV (Cayman), LLC


By:

/s/ Xiangmin Cui

Name:  Xiangmin Cui

Title:  Manager



Decheng Capital Global Healthcare Fund (Master), LP


By:

Decheng Capital Global Healthcare GP, LLC

Its:

 General Partner


By:

Decheng Capital LLC

Its:

Manager


By:

/s/ Xiangmin Cui

Name:  Xiangmin Cui

Title:  Manager



Decheng Capital Global Healthcare GP, LLC


By:

Decheng Capital LLC

Its:

Manager


By:

/s/ Xiangmin Cui

Name:  Xiangmin Cui

Title:  Manager



Xiangmin Cui


/s/ Xiangmin Cui





Aardvark Therapeutics (NASDAQ:AARD)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025 Click aqui para mais gráficos Aardvark Therapeutics.
Aardvark Therapeutics (NASDAQ:AARD)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025 Click aqui para mais gráficos Aardvark Therapeutics.